Sotera Health (NASDAQ:SHC) Shares Sold by Gtcr LLC

Gtcr LLC lowered its position in Sotera Health (NASDAQ:SHC - Free Report) by 16.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,215,301 shares of the company's stock after selling 10,000,000 shares during the period. Sotera Health comprises approximately 64.1% of Gtcr LLC's investment portfolio, making the stock its biggest position. Gtcr LLC owned approximately 17.38% of Sotera Health worth $821,896,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. Wedmont Private Capital grew its stake in Sotera Health by 6.5% in the 3rd quarter. Wedmont Private Capital now owns 10,915 shares of the company's stock valued at $169,000 after acquiring an additional 664 shares during the period. First Citizens Bank & Trust Co. lifted its holdings in Sotera Health by 5.0% during the third quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company's stock valued at $239,000 after purchasing an additional 677 shares in the last quarter. CWM LLC grew its position in shares of Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company's stock valued at $25,000 after purchasing an additional 993 shares during the period. GAMMA Investing LLC increased its stake in shares of Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after purchasing an additional 1,660 shares in the last quarter. Finally, TD Asset Management Inc raised its position in shares of Sotera Health by 1.5% during the 2nd quarter. TD Asset Management Inc now owns 123,454 shares of the company's stock worth $1,465,000 after purchasing an additional 1,800 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Trading Up 1.2 %

NASDAQ SHC traded up $0.15 on Wednesday, reaching $13.10. 976,140 shares of the company were exchanged, compared to its average volume of 1,341,059. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The business's fifty day moving average price is $15.46 and its 200 day moving average price is $14.01. The stock has a market capitalization of $3.71 billion, a P/E ratio of 51.80 and a beta of 2.08. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. During the same period in the previous year, the firm posted $0.18 EPS. The company's revenue was up 8.5% compared to the same quarter last year. Analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Analyst Ratings Changes

SHC has been the topic of several research analyst reports. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Barclays boosted their price target on Sotera Health from $14.00 to $17.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 6th. Finally, Citigroup raised their price objective on Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a report on Wednesday, November 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $16.50.

Insider Activity

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the transaction, the director now owns 49,215,301 shares of the company's stock, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 55.12% of the company's stock.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.